542771 NOVATEOR

Novateor Research Laboratories Share Price

 

 

Start SIP in NOVATEOR

Start SIP

Performance

  • Low
  • ₹29
  • High
  • ₹29
  • 52 Week Low
  • ₹20
  • 52 Week High
  • ₹58
  • Open Price₹29
  • Previous Close₹29
  • Volume3,000
  • 50 DMA₹34.75
  • 100 DMA₹34.89
  • 200 DMA₹29.63

Investment Returns

  • Over 1 Month + 43.43%
  • Over 3 Month + 6.67%
  • Over 6 Month -44.51%
  • Over 1 Year -32.79%

Smart Investing Starts Here Start SIP with Novateor Research Laboratories for Steady Growth!

Invest Now

Novateor Research Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 213.1
  • PEG Ratio
  • -
  • Market Cap Cr
  • 17
  • P/B Ratio
  • 1.5
  • Average True Range
  • 3.14
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -4.2
  • RSI
  • 46.45
  • MFI
  • 47.27

Novateor Research Laboratories Financials

Novateor Research Laboratories Technicals

EMA & SMA

Current Price
₹28.80
0 (0%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹29.50
  • 50 Day
  • ₹34.75
  • 100 Day
  • ₹34.89
  • 200 Day
  • ₹29.63

Resistance and Support

28.8 Pivot Speed
  • R3 28.80
  • R2 28.80
  • R1 28.80
  • S1 28.80
  • S2 28.80
  • S3 28.80

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Novateor Research Laboratories has an operating revenue of Rs. 6.45 Cr. on a trailing 12-month basis. An annual revenue growth of 92% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 70 indicates it belongs to a poor industry group of Cosmetics/Personal Care and a Master Score of E is the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Novateor Research Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Half Yearly Results
2025-09-03 A.G.M.
2025-05-30 Audited Results
2024-11-14 Half Yearly Results
2024-08-29 Others Inter alia, to consider : 1. To make second call of 25% of issue price of the preferential allotment of warrants. 2. To consider and approve the matter related to ensuing Annual Meeting of the company

Novateor Research Laboratories F&O

Novateor Research Laboratories Shareholding Pattern

50.9%
29.9%
19.2%

About Novateor Research Laboratories

  • NSE Symbol
  • NOVATEOR
  • BSE Symbol
  • 542771
  • Managing Director
  • Mr. Navdeep Subhashbhai Mehta
  • ISIN
  • INE08JY01013

Similar Stocks to Novateor Research Laboratories

Novateor Research Laboratories FAQs

Novateor Research Laboratories share price is ₹28 As on 11 January, 2026 | 20:09

The Market Cap of Novateor Research Laboratories is ₹17.4 Cr As on 11 January, 2026 | 20:09

The P/E ratio of Novateor Research Laboratories is 213.1 As on 11 January, 2026 | 20:09

The PB ratio of Novateor Research Laboratories is 1.5 As on 11 January, 2026 | 20:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23